JAK2V617F-Positive Patients with Essential Thrombocythemia or Early Primary Myelofibrosis: The Impact of Histological Diagnosis on Outcome

被引：0
|
作者：
Polverelli, Nicola [1 ]
Latagliata, Roberto [2 ]
Palumbo, Giuseppe A. [3 ]
Tieghi, Alessia [4 ]
Perricone, Margherita [1 ]
Breccia, Massimo [5 ]
Catani, Lucia [1 ]
Merli, Francesco [6 ]
Ottaviani, Emanuela [7 ]
Alimena, Giuliana [8 ]
Martinelli, Giovanni [9 ]
Cavo, Michele [10 ]
Vianelli, Nicola [1 ]
Palandri, Francesca [7 ]
机构：
[1] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy
[2] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy
[3] Univ Catania, Div Hematol, Osped Ferrarotto, Catania, Italy
[4] Azienda Osped Arcispedale Santa Maria Nuova, Div Hematol, Reggio Emilia, Italy
[5] Univ Roma La Sapienza, Dipartimento Ematol & Biotecnol, Rome, Italy
[6] Arcispedale Santa Maria Nuova, Hematol Unit, Ist Ricovero & Cura Carattere Sci, Reggio Emilia, Italy
[7] Univ Bologna, Bologna, Italy
[8] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Hematol, Rome, Italy
[9] Univ Bologna, Seragnoli Inst Hematol, Bologna, Italy
[10] Univ Bologna, Seragnoli Inst Hematol, Sch Med, Bologna, Italy
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Proteomic study of the impact of the JAK2-V617F mutation on the phenotype of essential thrombocythemia
    Mossuz, Pascal
    Arlotto, Marie
    Hermouet, Sylvie
    Bouamrani, Ali
    Lippert, Eric
    Girodon, Francois
    Dobo, Irene
    Vincent, Praloran
    Cahn, Jean Yves
    Berger, Francois
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (12) : 1642 - 1647
  • [42] Reduced Production of JAK2V617F-positive Microparticles at Mild Hypothermia
    Hekimoglu, Hilal
    Demirtas, Esra Nur
    Sozer, Selcuk
    IN VIVO, 2023, 37 (04): : 1680 - 1687
  • [43] Major Hematological Response Is the Main Factor for Achieving a Major Molecular Response in JAK2V617F-Positive Essential Thrombocythemia and Polycythemia Vera Patients Treated with Hydroxyurea
    Besses, C.
    Alvarez-Larran, A.
    Martinez-Aviles, L.
    Longaron, R.
    Serrano, S.
    Bellosillo, B.
    BLOOD, 2008, 112 (11) : 246 - 247
  • [44] Gain of function in Jak2V617F-positive T-cells
    Nishanth, G.
    Wolleschak, D.
    Fahldieck, C.
    Fischer, T.
    Mullally, A.
    Perner, F.
    Schnoeder, T. M.
    Just, S.
    Heidel, F. H.
    Schuelter, D.
    LEUKEMIA, 2017, 31 (04) : 1000 - 1003
  • [45] B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis
    Bogani, Costanza
    Guglielmelli, Paola
    Antonioli, Elisabetta
    Pancrazzi, Alessandro
    Bosi, Alberto
    Vannucchi, Alessandro Maria
    HAEMATOLOGICA, 2007, 92 (02) : 258 - 259
  • [46] Exploring redox vulnerabilities in JAK2V617F-positive cellular models
    Lima, Keli
    Lopes, Lucia Rossetti
    Machado-Neto, Joao Agostinho
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (04) : 430 - 436
  • [47] Gain of function in Jak2V617F-positive T-cells
    G Nishanth
    D Wolleschak
    C Fahldieck
    T Fischer
    A Mullally
    F Perner
    T M Schnöder
    S Just
    F H Heidel
    D Schlüter
    Leukemia, 2017, 31 : 1000 - 1003
  • [48] DEVELOPMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA IN A PATIENT WITH JAK2V617F POSITIVE ESSENTIAL THROMBOCYTHEMIA
    Ertop, S.
    Aslaner, M.
    Gunes, G.
    Malkan, U. Y.
    Tekin, I.
    LEUKEMIA RESEARCH, 2014, 38 : S42 - S42
  • [49] Assessment of JAK2 V617F mutation in Tunisian patients with essential thrombocythemia
    Belhiba, M.
    Bellaaj, H.
    Keskes, L.
    Frikha, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1016 - 1016
  • [50] JAK2 V617F mutation in essential thrombocythemia.
    Ahn, Jeong Yeal
    Park, Pil Whan
    Seo, Yiel Hea
    Shin, Dong-Bok
    Lee, Jae-Hoon
    Yoo, Soo-Jin
    Bang, Soo-Mee
    BLOOD, 2006, 108 (11) : 318B - 318B
12345